Drugs Made In America Acquisition Corp. Company Profile
NASDAQ: DMAAFinancial ServicesShell CompaniesUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Drugs Made In America Acquisition at a glance
Drugs Made In America Acquisition Corp. (NASDAQ: DMAA) is a Shell Companies company in the Financial Services sector headquartered in New York, NY. Drugs Made In America Acquisition is led by Mr. Roger Bendelac. The company's shares have traded publicly since 2025.
At a market capitalization of $263.2 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0002028614, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Drugs Made In America Acquisition do?
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
Business description based on the company's public filings.
Company information
- Legal name
- Drugs Made In America Acquisition Corp.
- Ticker
- NASDAQ: DMAA
- Sector
- Financial Services
- Industry
- Shell Companies
- CEO
- Mr. Roger Bendelac
- Headquarters
- 420 Lexington Avenue, New York, NY, United States
- Phone
- 646 726 7074
- IPO year
- 2025
- Market cap
- $263.16M
- SEC CIK
- 0002028614
Companies similar to Drugs Made In America Acquisition
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| NTWONewbury Street II Acquisition Corp Class A | 10.82 | 0.00% | $260.94M | vs DMAA |
| VLOSVelos Acquisition I Corp. Class A | 10.79 | +0.28% | $253.25M | vs DMAA |
| SCIISC II Acquisition Corp. Class A | 10.17 | 0.00% | $253.21M | vs DMAA |
| OHACOceanhawk Acquisition Corp. Class A | 9.99 | +0.10% | $250.38M | vs DMAA |
| MTAKMarket Technology Acquisition Corp Class A | 9.84 | -0.10% | $275.97M | vs DMAA |
| IPHXInflection Point Acquisition Corp. VIII Class A | 9.90 | 0.00% | $247.50M | vs DMAA |
| PNAQPinnacle Acquisition Corporation Class A | 9.84 | +0.10% | $246.00M | vs DMAA |
| SAMOSamos Energy Acquisition Corporation Class A | 9.80 | 0.00% | $281.75M | vs DMAA |